Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor
about
A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions.Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3.Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membraneHIV type 1 Gag as a target for antiviral therapyIdentification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipidsRole of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infectionThe Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrixDifferential membrane binding of the human immunodeficiency virus type 1 matrix proteinUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesNucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsReal-time visualization of HIV-1 GAG trafficking in infected macrophagesTargeting of Moloney murine leukemia virus gag precursor to the site of virus buddingSingle amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle productionLipids and membrane microdomains in HIV-1 replicationPoint Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl SwitchEntropic switch regulates myristate exposure in the HIV-1 matrix proteinBiophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix proteinCrystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyMode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replicationEfficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domainAltering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccineInteraction of Moloney murine leukemia virus matrix protein with IQGAPTracking interspecies transmission and long-term evolution of an ancient retrovirus using the genomes of modern mammalsImperfect DNA mirror repeats in the gag gene of HIV-1 (HXB2) identify key functional domains and coincide with protein structural elements in each of the mature proteins.Considering protonation as a posttranslational modification regulating protein structure and function.Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.Features of Maternal HIV-1 Associated with Lack of Vertical TransmissionInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmissionFIV Gag: virus assembly and host-cell interactions.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent mannerCleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
P2860
Q24527227-D0D27CC9-AA66-4531-89A6-F0CE4BE2D919Q24531508-B3670EE9-1368-4EC1-8F4B-FCBEFC0023C4Q24563708-094F5C61-55C2-4F9F-BFB4-2D8793BD2DDDQ24614498-8C163C35-2F3E-4C5A-9B32-1423A3C4A0FFQ24646680-0542807E-3489-449E-8EE4-954CF967BCFDQ24673913-F804430C-14DC-4A5E-9A23-9E05DB0D1E0BQ24673997-5A01C408-84F2-43E9-B8EB-E748412BF31DQ24679629-D99CCAB5-59D5-4C45-9DEF-B2FEF0E4227CQ27021655-D18F8313-0D4D-4C16-90AE-C13CBC62D2E1Q27312753-AB97E5BE-B335-49A3-9F76-1F66833D1F80Q27318996-EBA49572-3297-43FB-8975-8AE6428477A0Q27483437-6B4717FD-BDD6-4E97-B9BA-AD64FBC4AD7CQ27485930-EC17F12E-AB2E-4965-9173-EE52C864B811Q27489393-EE2A9F37-598E-4621-B72A-6CC52BC53508Q27640933-CE90E2D1-5B5B-46E8-A5D0-9AD92006CA07Q27642873-6444100E-3DC9-41A4-A973-82DC0840AB7AQ27678797-38EB34CE-6FF1-4208-AD9F-0654E87949DEQ27732646-44AC6528-39B8-4D3B-9F41-F07E6E267A8CQ28368266-485FFEFC-6397-4FF3-B5C9-3FDF3060DF85Q28478202-157724B4-49E4-4EC4-944E-738DD8C4F6B1Q28482252-5E8CBEB4-7014-4041-8605-2282CAFD6732Q28589348-829BF2A8-4A8A-4C39-977D-231EF90C95BAQ28602397-B0DCF808-449F-43BA-B545-10BDF5FC0FC0Q30365424-F6B4AD8F-E059-4CF6-AA6E-EC3874977832Q30427740-A507FFBB-C1B4-4E84-8BCE-E62669FC3163Q30443327-982C8EE0-5A4E-4762-A3A4-9BFF56DA1A51Q33555231-DFAC8DB3-3907-4504-9FC3-D0C67691769FQ33643700-01FA7FEE-5568-4D43-AEA7-F6AE766CD20DQ33647588-CFF9E65B-F297-4D30-99D3-F62065DF5ED0Q33652796-A56D1948-1E21-4DE0-ABDF-A3FA83919D86Q33653971-C694AA68-5314-4AC4-8D6A-255B7C988AEAQ33780632-750C196B-AC25-448F-8E91-DD18EF4D19ABQ33782781-C521475E-4046-4168-86FC-6E2CA5914CC1Q33784101-2B54B966-1D26-4756-8DB1-C532CBB515C0Q33784754-7D32E451-3D7A-4F5C-BFFE-D59F8DE56827Q33785367-0B8FE8E3-780F-4E2F-888F-CD1874ACD529Q33785977-B648C796-38B3-4BDE-9411-0E1473271D54Q33800293-4268BB96-348D-4BF6-882E-75FFC0522993Q33806715-A0502C36-DA02-4653-9CED-2324690AA225Q33813648-A8BF4A04-54F9-4DCB-8D8B-30D7A02CF110
P2860
Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Mutations in the N-terminal re ...... transport of the Gag precursor
@ast
Mutations in the N-terminal re ...... transport of the Gag precursor
@en
type
label
Mutations in the N-terminal re ...... transport of the Gag precursor
@ast
Mutations in the N-terminal re ...... transport of the Gag precursor
@en
prefLabel
Mutations in the N-terminal re ...... transport of the Gag precursor
@ast
Mutations in the N-terminal re ...... transport of the Gag precursor
@en
P2093
P2860
P1433
P1476
Mutations in the N-terminal re ...... transport of the Gag precursor
@en
P2093
P2860
P304
P407
P577
1993-11-01T00:00:00Z